What is the recommended intramuscular dose of rabies immune globulin for post‑exposure prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rabies Immunoglobulin Dosing for Intramuscular Administration

The recommended dose of rabies immune globulin (RIG) for post-exposure prophylaxis is 20 IU/kg body weight, administered once on day 0 at the time of first vaccine dose. 1, 2

Dosing Calculation and Administration

The dose is weight-based and straightforward:

  • 20 IU/kg body weight (or 0.133 mL/kg for standard 150 IU/mL formulations)
  • For example, a 70 kg patient requires: 20 IU/kg × 70 kg = 1,400 IU total dose 2

Critical Administration Principles

Anatomical infiltration is the priority: If anatomically feasible, infiltrate the full calculated dose around and into all wound sites first. Any remaining volume should then be administered intramuscularly at a site distant from vaccine administration 1, 2. This dual approach ensures immediate local neutralization of virus at the exposure site while providing systemic antibody coverage.

The evidence from multiple ACIP guidelines consistently emphasizes that no more than the recommended 20 IU/kg dose should be given, as excess RIG may partially suppress the active antibody production from the vaccine series 1. This is a critical pitfall to avoid—overdosing can compromise vaccine efficacy.

Timing Window

  • Optimal timing: Day 0 (same day as first vaccine dose)
  • Acceptable window: Can be administered up to and including day 7 of the PEP series if not given initially 1
  • After day 7: RIG is generally not recommended as endogenous antibody production from vaccine should be established

Key Administration Details

Never administer RIG:

  • In the same syringe as rabies vaccine
  • At the same anatomical site as the first vaccine dose 1, 2

Subsequent vaccine doses (days 3,7,14) can be given in the same anatomic location where RIG was previously administered 1

Special Populations

Previously vaccinated persons: RIG should NOT be administered—they only need a 2-dose vaccine series on days 0 and 3 1

Immunocompromised patients: Still receive the standard 20 IU/kg RIG dose, but require a 5-dose vaccine series (days 0,3,7,14,28) instead of the standard 4-dose regimen 1

Pediatric patients: Use the same weight-based dose (20 IU/kg) as adults—no dose adjustment needed 1, 3

Common Pitfalls to Avoid

  1. Inadequate wound infiltration: Real-world data shows only 56% of eligible patients receive proper wound infiltration despite 91% receiving RIG overall 4. Always attempt to infiltrate wounds when anatomically feasible.

  2. Dose rounding: While dose rounding to nearest vial size has been shown safe and cost-effective in practice 5, the official recommendation remains precise weight-based dosing at 20 IU/kg 1, 2.

  3. Giving RIG to previously vaccinated persons: This is unnecessary and wastes resources—verify vaccination history before administering 1.

  4. Exceeding recommended dose: More is not better with RIG; excess doses interfere with vaccine-induced immunity 1.

The evidence base for this 20 IU/kg dosing is robust, stemming from ACIP guidelines 1 and FDA labeling 2, with supporting clinical trial data demonstrating adequate neutralizing antibody levels and excellent safety profiles 2, 3, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.